Cite
Cortinovis D, Grosso F, Carlucci L, et al. Trabectedin in Malignant Pleural Mesothelioma: Results From the Multicentre, Single Arm, Phase II ATREUS Study. Clin Lung Cancer. 2020;22(4):361-370.e3doi: 10.1016/j.cllc.2020.06.028.
Cortinovis, D., Grosso, F., Carlucci, L., Zucali, P. A., Pasello, G., Tiseo, M., Sperandi, F., Hollander, L., Galli, F., Torri, V., Rulli, E., Canova, S., Maconi, A., Bidoli, P., Ceresoli, G. L., D'Incalci, M. (2021). Trabectedin in Malignant Pleural Mesothelioma: Results From the Multicentre, Single Arm, Phase II ATREUS Study. Clinical lung cancer, 22(4), 361-370.e3. https://doi.org/10.1016/j.cllc.2020.06.028
Cortinovis, Diego, et al. "Trabectedin in Malignant Pleural Mesothelioma: Results From the Multicentre, Single Arm, Phase II ATREUS Study." Clinical lung cancer vol. 22,4 (2021): 361-370.e3. doi: https://doi.org/10.1016/j.cllc.2020.06.028
Cortinovis D, Grosso F, Carlucci L, Zucali PA, Pasello G, Tiseo M, Sperandi F, Hollander L, Galli F, Torri V, Rulli E, Canova S, Maconi A, Bidoli P, Ceresoli GL, D'Incalci M. Trabectedin in Malignant Pleural Mesothelioma: Results From the Multicentre, Single Arm, Phase II ATREUS Study. Clin Lung Cancer. 2021 Jul;22(4):361-370.e3. doi: 10.1016/j.cllc.2020.06.028. Epub 2020 Jul 03. PMID: 32732073.
Copy
Download .nbib